About Huadong Medicine Company

The company was founded in 1993 and listed on the Shenzhen Stock Exchange in December 1999. After more than 20 years of development, the company's business covers the entire pharmaceutical industry chain, with the pharmaceutical industry as the lead, while expanding the pharmaceutical business, medical and aesthetic industry, and industrial microbiology business. It has developed into a large-scale comprehensive pharmaceutical listed company integrating pharmaceutical R&D, production and distribution. The company's business covers the entire pharmaceutical industry chain and has four major business segments: pharmaceutical industry, pharmaceutical commerce, medical aesthetics, and industrial microbiology. The company's main products are the pharmaceutical industry sector, the industrial microbiology sector, the pharmaceutical business sector, and the medical and aesthetic business sector. Corporate honors: Shenzhen Stock Exchange China Securities ESG rating AAA, WINDESG rating A, and won the “Top 100 Chinese Listed Companies ESG” by the Securities Times in the 17th China Listed Company Value; ranked 358 in the “Fortune” China 500 in the 14th year; won the “2023 China Top 500 Private Enterprises” and “2023 China's Top 500 Private Enterprises” by the All-China Federation of Industry and Commerce; Selected as the “2022 China Pharmaceutical Industry Top 100” series list; won the 2022 China Pharmaceutical Industry Top 10” “2023 Top 20 Chinese Pharmaceutical Listed Companies with Competitiveness”, Huaxia Times's “2023 Top Ten Innovative Pharmaceutical Companies”; listed on the “2023 China Drug Research and Development Comprehensive Strength Ranking TOP100” and “2023 China Pharmaceutical R&D Strength Ranking TOP100”, etc.